{"id":9586,"date":"2025-12-26T09:09:03","date_gmt":"2025-12-26T14:09:03","guid":{"rendered":"https:\/\/fifarma.org\/?p=9586"},"modified":"2026-03-05T12:32:14","modified_gmt":"2026-03-05T17:32:14","slug":"que-es-el-ich-y-por-que-es-clave-para-fortalecer-la-regulacion-de-medicamentos-en-america-latina-copy","status":"publish","type":"post","link":"https:\/\/fifarma.org\/en\/que-es-el-ich-y-por-que-es-clave-para-fortalecer-la-regulacion-de-medicamentos-en-america-latina-copy\/","title":{"rendered":"2025: un a\u00f1o en el que avanzamos juntos por la\u00a0salud en Am\u00e9rica Latina\u00a0"},"content":{"rendered":"<figure class=\"wp-block-image alignleft size-large is-resized\"><img fetchpriority=\"high\" decoding=\"async\" width=\"1024\" height=\"1024\" src=\"https:\/\/fifarma.org\/wp-content\/uploads\/2025\/12\/Blog-Fin-de-ano_Cuadrada-Blog-2-1024x1024.jpg\" alt=\"\" class=\"wp-image-9590\" style=\"width:439px;height:auto\" srcset=\"https:\/\/fifarma.org\/wp-content\/uploads\/2025\/12\/Blog-Fin-de-ano_Cuadrada-Blog-2-1024x1024.jpg 1024w, https:\/\/fifarma.org\/wp-content\/uploads\/2025\/12\/Blog-Fin-de-ano_Cuadrada-Blog-2-300x300.jpg 300w, https:\/\/fifarma.org\/wp-content\/uploads\/2025\/12\/Blog-Fin-de-ano_Cuadrada-Blog-2-150x150.jpg 150w, https:\/\/fifarma.org\/wp-content\/uploads\/2025\/12\/Blog-Fin-de-ano_Cuadrada-Blog-2-768x768.jpg 768w, https:\/\/fifarma.org\/wp-content\/uploads\/2025\/12\/Blog-Fin-de-ano_Cuadrada-Blog-2-1536x1536.jpg 1536w, https:\/\/fifarma.org\/wp-content\/uploads\/2025\/12\/Blog-Fin-de-ano_Cuadrada-Blog-2-2048x2048.jpg 2048w, https:\/\/fifarma.org\/wp-content\/uploads\/2025\/12\/Blog-Fin-de-ano_Cuadrada-Blog-2-12x12.jpg 12w\" sizes=\"(max-width: 1024px) 100vw, 1024px\" \/><\/figure>\n\n\n\n<p><em><em>En 2025,\u00a0la\u00a0labor\u00a0de FIFARMA estuvo marcada\u00a0por la evidencia, la colaboraci\u00f3n y una mirada regional compartida. A lo largo del a\u00f1o, impulsamos espacios de di\u00e1logo que reflejan c\u00f3mo avanzar juntos sigue siendo clave para fortalecer la innovaci\u00f3n en salud en Am\u00e9rica Latina.<\/em>\u00a0<\/em><\/p>\n\n\n\n<p>En FIFARMA creemos que cuando la ciencia, la evidencia y la colaboraci\u00f3n se encuentran, es posible generar impacto. Esa convicci\u00f3n marc\u00f3 nuestra&nbsp;labor&nbsp;a lo largo de 2025 y se tradujo en una agenda regional construida desde el esfuerzo colectivo.&nbsp;<\/p>\n\n\n\n<p>Gracias al compromiso&nbsp;y acompa\u00f1amiento&nbsp;de nuestras 19 compa\u00f1\u00edas miembro, 11 asociaciones locales y socios multilaterales, durante el a\u00f1o seguimos impulsando acciones orientadas a acercar la innovaci\u00f3n en salud a m\u00e1s personas en Am\u00e9rica Latina. Este recorrido no fue el resultado de iniciativas aisladas, sino de una forma de trabajar basada en la articulaci\u00f3n, el di\u00e1logo t\u00e9cnico y una mirada regional compartida.&nbsp;<\/p>\n\n\n\n<p><strong>Evidencia y colaboraci\u00f3n como motores del avance<\/strong>&nbsp;<\/p>\n\n\n\n<p>A lo largo de 2025, desde FIFARMA pusimos la evidencia en el centro de la conversaci\u00f3n regional. La publicaci\u00f3n de cinco estudios permiti\u00f3 aportar informaci\u00f3n actualizada y rigurosa&nbsp;al&nbsp;ecosistema de salud:&nbsp;<\/p>\n\n\n\n<ul class=\"wp-block-list\">\n<li>Patient\u00a0W.A.I.T.\u00a0Indicador\u00a02025\u00a0junto con\u00a0IQVIA.\u00a0<\/li>\n<\/ul>\n\n\n\n<ul class=\"wp-block-list\">\n<li>El\u00a0reporte\u00a0de Competitividad e Inversi\u00f3n Biofarmac\u00e9utica (BCI)\u00a0junto con\u00a0Pugatch\u00a0Consilium.\u00a0<\/li>\n<\/ul>\n\n\n\n<ul class=\"wp-block-list\">\n<li>An\u00e1lisis de Pr\u00e1cticas Presupuestarias en Salud en 8 pa\u00edses de Am\u00e9rica Latina\u00a0junto con\u00a0Duke\u00a0University.\u00a0<\/li>\n<\/ul>\n\n\n\n<ul class=\"wp-block-list\">\n<li>Observatorio de Buenas Pr\u00e1cticas Regulatorias\u00a0junto con\u00a0INNOS.\u00a0<\/li>\n<\/ul>\n\n\n\n<ul class=\"wp-block-list\">\n<li>Investigaci\u00f3n Cl\u00ednica en\u00a0Latinoam\u00e9rica: Informe\u00a0de recomendaciones\u00a0basadas\u00a0en\u00a0mejores pr\u00e1cticas\u00a0junto con CIRS.\u00a0<\/li>\n<\/ul>\n\n\n\n<p>Estos insumos fueron presentados y discutidos en espacios de alto nivel como foros internacionales, encuentros t\u00e9cnicos y escenarios acad\u00e9micos.&nbsp;Solo durante el a\u00f1o, nuestros reportes superaron las 1.500 descargas y los contenidos de FIFARMA registraron m\u00e1s de 68.000 visitas, reflejando el inter\u00e9s regional por contar con informaci\u00f3n basada en datos.&nbsp;<\/p>\n\n\n\n<p>Este trabajo se complement\u00f3 con&nbsp;la organizaci\u00f3n de&nbsp;m\u00e1s de 25 eventos y&nbsp;la participaci\u00f3n de&nbsp;m\u00e1s de 20 encuentros externos en 14 pa\u00edses, adem\u00e1s de 34&nbsp;<em>webinars<\/em>&nbsp;abiertos a audiencias de toda la regi\u00f3n.&nbsp;Igualmente, a&nbsp;trav\u00e9s de la Academia FIFARMA, m\u00e1s de 250 personas se formaron en temas clave para el sector, fortaleciendo&nbsp;sus&nbsp;capacidades y promoviendo una visi\u00f3n compartida sobre innovaci\u00f3n en salud.&nbsp;<\/p>\n\n\n\n<p><strong>Avances construidos desde distintos frentes de trabajo<\/strong>&nbsp;<\/p>\n\n\n\n<p>En el \u00e1mbito de&nbsp;Pol\u00edticas de&nbsp;Salud, impulsamos discusiones regionales sobre competitividad e inversi\u00f3n biofarmac\u00e9utica, aportando estudios y herramientas que fortalecieron el debate t\u00e9cnico y ampliaron su alcance en espacios regionales e internacionales. En este marco, la propiedad intelectual tuvo un rol central como habilitador de la innovaci\u00f3n. A trav\u00e9s del lanzamiento del IP&nbsp;Toolkit&nbsp;y de espacios de di\u00e1logo, desde FIFARMA contribuimos a una conversaci\u00f3n regional sobre c\u00f3mo marcos s\u00f3lidos de propiedad intelectual favorecen el desarrollo de la innovaci\u00f3n en salud y la atracci\u00f3n de inversi\u00f3n sostenible.&nbsp;<\/p>\n\n\n\n<p>En&nbsp;Valor y&nbsp;Acceso a la&nbsp;Innovaci\u00f3n, el&nbsp;Patient&nbsp;W.A.I.T.&nbsp;Indicador&nbsp;2025&nbsp;permiti\u00f3 volver a poner en el centro de la conversaci\u00f3n la importancia del acceso oportuno a medicamentos innovadores. En esa misma l\u00ednea, desarrollamos el An\u00e1lisis de Pr\u00e1cticas Presupuestarias en Salud en ocho pa\u00edses de Am\u00e9rica Latina, un estudio que ampli\u00f3&nbsp;la conversaci\u00f3n&nbsp;sobre c\u00f3mo las decisiones de planificaci\u00f3n financiera inciden directamente en el acceso a la innovaci\u00f3n y en el bienestar de los pacientes.&nbsp;&nbsp;<\/p>\n\n\n\n<p>Desde&nbsp;Asuntos&nbsp;Regulatorios y&nbsp;Farmacovigilancia, la cooperaci\u00f3n t\u00e9cnica fue un eje clave durante 2025. La serie de&nbsp;<em>webinars<\/em>&nbsp;LATAM ICH reuni\u00f3 a participantes de 25 pa\u00edses y a 14 autoridades regulatorias, fortaleciendo el intercambio de buenas pr\u00e1cticas. Este esfuerzo se complement\u00f3 con la segunda Misi\u00f3n de Reguladores en Argentina, que convoc\u00f3 a representantes de 12 agencias en un espacio de di\u00e1logo t\u00e9cnico orientado a la confianza, la transformaci\u00f3n digital y la colaboraci\u00f3n regional.&nbsp;<\/p>\n\n\n\n<p>De cara al&nbsp;2026, desde FIFARMA&nbsp;seguiremos&nbsp;avanzando guiados por la evidencia, la colaboraci\u00f3n regional y el compromiso de fortalecer los sistemas de salud de Am\u00e9rica Latina.&nbsp;<\/p>\n\n\n\n<p>Porque el progreso en innovaci\u00f3n en salud no se construye desde un solo lugar.&nbsp;<\/p>\n\n\n\n<p>Se construye cuando avanzamos juntos.&nbsp;<\/p>\n\n\n\n<p><\/p>\n\n    <div class=\"xs_social_share_widget xs_share_url after_content \t\tmain_content  wslu-style-1 wslu-share-box-shaped wslu-fill-colored wslu-none wslu-share-horizontal wslu-theme-font-no wslu-main_content\">\n\n\t\t\n        <ul>\n\t\t\t        <\/ul>\n    <\/div>","protected":false},"excerpt":{"rendered":"<p>En 2025,\u00a0la\u00a0labor\u00a0de FIFARMA estuvo marcada\u00a0por la evidencia, la colaboraci\u00f3n y una mirada regional compartida. A lo largo del a\u00f1o, impulsamos espacios de di\u00e1logo que reflejan c\u00f3mo avanzar juntos sigue siendo clave para fortalecer la innovaci\u00f3n en salud en Am\u00e9rica Latina.\u00a0 En FIFARMA creemos que cuando la ciencia, la evidencia y la colaboraci\u00f3n se encuentran, es [&hellip;]<\/p>","protected":false},"author":24,"featured_media":9591,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"postBodyCss":"","postBodyMargin":[],"postBodyPadding":[],"postBodyBackground":{"backgroundType":"classic","gradient":""},"enableOnePageScrollInPage":false,"onePageScrollCss":"","onePageScrollSpeed":1000,"onePageScrollAnimation":"easeInOutQuad","onePageScrollShowDotNavigation":true,"onePageScrollNavigation":"scaleUp","onePageScrollNavigationPosition":"right","onePageScrollNavigationHorizontal":[],"onePageScrollNavigationVertical":[],"onePageScrollNavigationSpacing":[],"onePageScrollNavigationColor":"#00ff0d","onePageScrollNavigationColorHover":"#00ff0d","onePageScrollNavigationColorActive":"#00ff0d","onePageScrollNavigationIcon":[],"onePageScrollNavigationWidth":[],"onePageScrollNavigationWidthHover":[],"onePageScrollNavigationWidthActive":[],"onePageScrollNavigationHeight":[],"onePageScrollNavigationHeightHover":[],"onePageScrollNavigationHeightActive":[],"onePageScrollNavigationBorder":[],"onePageScrollNavigationBorderHover":[],"onePageScrollNavigationBorderActive":[],"onePageScrollNavigationBorderRadius":[],"onePageScrollNavigationBorderRadiusHover":[],"onePageScrollNavigationBorderRadiusActive":[],"onePageScrollNavigationTooltipTypography":[],"onePageScrollNavigationTooltipColor":"#ffffff","onePageScrollNavigationTooltipColorHover":"","onePageScrollNavigationTooltipBgColor":"#00ff0d","onePageScrollNavigationTooltipBgColorHover":"","onePageScrollNavigationTooltipPadding":[],"onePageScrollNavigationTooltipPaddingHover":[],"onePageScrollNavigationTooltipBorderRadius":[],"onePageScrollNavigationTooltipBorderRadiusHover":[],"pageSettingsCustomCss":"","footnotes":""},"categories":[177],"tags":[26,60,49],"class_list":["post-9586","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-comunicado","tag-america-latina","tag-fifarma","tag-salud"],"yoast_head":"<!-- This site is optimized with the Yoast SEO Premium plugin v26.7 (Yoast SEO v27.3) - https:\/\/yoast.com\/product\/yoast-seo-premium-wordpress\/ -->\n<title>2025: un a\u00f1o en el que avanzamos juntos por la\u00a0salud en Am\u00e9rica Latina\u00a0 - FIFARMA<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/fifarma.org\/en\/que-es-el-ich-y-por-que-es-clave-para-fortalecer-la-regulacion-de-medicamentos-en-america-latina-copy\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"2025: un a\u00f1o en el que avanzamos juntos por la\u00a0salud en Am\u00e9rica Latina\u00a0\" \/>\n<meta property=\"og:description\" content=\"En 2025,\u00a0la\u00a0labor\u00a0de FIFARMA estuvo marcada\u00a0por la evidencia, la colaboraci\u00f3n y una mirada regional compartida. A lo largo del a\u00f1o, impulsamos espacios de di\u00e1logo que reflejan c\u00f3mo avanzar juntos sigue siendo clave para fortalecer la innovaci\u00f3n en salud en Am\u00e9rica Latina.\u00a0 En FIFARMA creemos que cuando la ciencia, la evidencia y la colaboraci\u00f3n se encuentran, es [&hellip;]\" \/>\n<meta property=\"og:url\" content=\"https:\/\/fifarma.org\/en\/que-es-el-ich-y-por-que-es-clave-para-fortalecer-la-regulacion-de-medicamentos-en-america-latina-copy\/\" \/>\n<meta property=\"og:site_name\" content=\"FIFARMA\" \/>\n<meta property=\"article:published_time\" content=\"2025-12-26T14:09:03+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2026-03-05T17:32:14+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/fifarma.org\/wp-content\/uploads\/2025\/12\/Blog-Fin-de-ano_Banner-Blog-scaled.jpg\" \/>\n\t<meta property=\"og:image:width\" content=\"2560\" \/>\n\t<meta property=\"og:image:height\" content=\"1138\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<meta name=\"author\" content=\"fifarmacomunicaciones\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"fifarmacomunicaciones\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"4 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/fifarma.org\\\/que-es-el-ich-y-por-que-es-clave-para-fortalecer-la-regulacion-de-medicamentos-en-america-latina-copy\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/fifarma.org\\\/que-es-el-ich-y-por-que-es-clave-para-fortalecer-la-regulacion-de-medicamentos-en-america-latina-copy\\\/\"},\"author\":{\"name\":\"fifarmacomunicaciones\",\"@id\":\"https:\\\/\\\/fifarma.org\\\/#\\\/schema\\\/person\\\/f1731f7484686defa417316a8fe42068\"},\"headline\":\"2025: un a\u00f1o en el que avanzamos juntos por la\u00a0salud en Am\u00e9rica Latina\u00a0\",\"datePublished\":\"2025-12-26T14:09:03+00:00\",\"dateModified\":\"2026-03-05T17:32:14+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/fifarma.org\\\/que-es-el-ich-y-por-que-es-clave-para-fortalecer-la-regulacion-de-medicamentos-en-america-latina-copy\\\/\"},\"wordCount\":787,\"publisher\":{\"@id\":\"https:\\\/\\\/fifarma.org\\\/#organization\"},\"image\":{\"@id\":\"https:\\\/\\\/fifarma.org\\\/que-es-el-ich-y-por-que-es-clave-para-fortalecer-la-regulacion-de-medicamentos-en-america-latina-copy\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/fifarma.org\\\/wp-content\\\/uploads\\\/2025\\\/12\\\/Blog-Fin-de-ano_Banner-Blog-scaled.jpg\",\"keywords\":[\"america latina\",\"fifarma\",\"salud\"],\"articleSection\":[\"Comunicado\"],\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/fifarma.org\\\/que-es-el-ich-y-por-que-es-clave-para-fortalecer-la-regulacion-de-medicamentos-en-america-latina-copy\\\/\",\"url\":\"https:\\\/\\\/fifarma.org\\\/que-es-el-ich-y-por-que-es-clave-para-fortalecer-la-regulacion-de-medicamentos-en-america-latina-copy\\\/\",\"name\":\"2025: un a\u00f1o en el que avanzamos juntos por la\u00a0salud en Am\u00e9rica Latina\u00a0 - FIFARMA\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/fifarma.org\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/fifarma.org\\\/que-es-el-ich-y-por-que-es-clave-para-fortalecer-la-regulacion-de-medicamentos-en-america-latina-copy\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/fifarma.org\\\/que-es-el-ich-y-por-que-es-clave-para-fortalecer-la-regulacion-de-medicamentos-en-america-latina-copy\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/fifarma.org\\\/wp-content\\\/uploads\\\/2025\\\/12\\\/Blog-Fin-de-ano_Banner-Blog-scaled.jpg\",\"datePublished\":\"2025-12-26T14:09:03+00:00\",\"dateModified\":\"2026-03-05T17:32:14+00:00\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/fifarma.org\\\/que-es-el-ich-y-por-que-es-clave-para-fortalecer-la-regulacion-de-medicamentos-en-america-latina-copy\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/fifarma.org\\\/que-es-el-ich-y-por-que-es-clave-para-fortalecer-la-regulacion-de-medicamentos-en-america-latina-copy\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/fifarma.org\\\/que-es-el-ich-y-por-que-es-clave-para-fortalecer-la-regulacion-de-medicamentos-en-america-latina-copy\\\/#primaryimage\",\"url\":\"https:\\\/\\\/fifarma.org\\\/wp-content\\\/uploads\\\/2025\\\/12\\\/Blog-Fin-de-ano_Banner-Blog-scaled.jpg\",\"contentUrl\":\"https:\\\/\\\/fifarma.org\\\/wp-content\\\/uploads\\\/2025\\\/12\\\/Blog-Fin-de-ano_Banner-Blog-scaled.jpg\",\"width\":2560,\"height\":1138},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/fifarma.org\\\/que-es-el-ich-y-por-que-es-clave-para-fortalecer-la-regulacion-de-medicamentos-en-america-latina-copy\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Portada\",\"item\":\"https:\\\/\\\/fifarma.org\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"2025: un a\u00f1o en el que avanzamos juntos por la\u00a0salud en Am\u00e9rica Latina\u00a0\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/fifarma.org\\\/#website\",\"url\":\"https:\\\/\\\/fifarma.org\\\/\",\"name\":\"FIFARMA\",\"description\":\"Federaci\u00f3n Latinoamericana de la Industria Farmac\u00e9utica\",\"publisher\":{\"@id\":\"https:\\\/\\\/fifarma.org\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/fifarma.org\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/fifarma.org\\\/#organization\",\"name\":\"Fifarma\",\"alternateName\":\"Federaci\u00f3n Latinoamericana de la Industria Farmac\u00e9utica\",\"url\":\"https:\\\/\\\/fifarma.org\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/fifarma.org\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"https:\\\/\\\/fifarma.org\\\/wp-content\\\/uploads\\\/2022\\\/10\\\/logo-fifarma.png\",\"contentUrl\":\"https:\\\/\\\/fifarma.org\\\/wp-content\\\/uploads\\\/2022\\\/10\\\/logo-fifarma.png\",\"width\":195,\"height\":39,\"caption\":\"Fifarma\"},\"image\":{\"@id\":\"https:\\\/\\\/fifarma.org\\\/#\\\/schema\\\/logo\\\/image\\\/\"}},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/fifarma.org\\\/#\\\/schema\\\/person\\\/f1731f7484686defa417316a8fe42068\",\"name\":\"fifarmacomunicaciones\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/8af54b74d81934872c5e9bf852bec4021ca6d3043cf2132e25087b2d09318d1c?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/8af54b74d81934872c5e9bf852bec4021ca6d3043cf2132e25087b2d09318d1c?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/8af54b74d81934872c5e9bf852bec4021ca6d3043cf2132e25087b2d09318d1c?s=96&d=mm&r=g\",\"caption\":\"fifarmacomunicaciones\"}}]}<\/script>\n<!-- \/ Yoast SEO Premium plugin. -->","yoast_head_json":{"title":"2025: un a\u00f1o en el que avanzamos juntos por la\u00a0salud en Am\u00e9rica Latina\u00a0 - FIFARMA","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/fifarma.org\/en\/que-es-el-ich-y-por-que-es-clave-para-fortalecer-la-regulacion-de-medicamentos-en-america-latina-copy\/","og_locale":"en_US","og_type":"article","og_title":"2025: un a\u00f1o en el que avanzamos juntos por la\u00a0salud en Am\u00e9rica Latina\u00a0","og_description":"En 2025,\u00a0la\u00a0labor\u00a0de FIFARMA estuvo marcada\u00a0por la evidencia, la colaboraci\u00f3n y una mirada regional compartida. A lo largo del a\u00f1o, impulsamos espacios de di\u00e1logo que reflejan c\u00f3mo avanzar juntos sigue siendo clave para fortalecer la innovaci\u00f3n en salud en Am\u00e9rica Latina.\u00a0 En FIFARMA creemos que cuando la ciencia, la evidencia y la colaboraci\u00f3n se encuentran, es [&hellip;]","og_url":"https:\/\/fifarma.org\/en\/que-es-el-ich-y-por-que-es-clave-para-fortalecer-la-regulacion-de-medicamentos-en-america-latina-copy\/","og_site_name":"FIFARMA","article_published_time":"2025-12-26T14:09:03+00:00","article_modified_time":"2026-03-05T17:32:14+00:00","og_image":[{"width":2560,"height":1138,"url":"https:\/\/fifarma.org\/wp-content\/uploads\/2025\/12\/Blog-Fin-de-ano_Banner-Blog-scaled.jpg","type":"image\/jpeg"}],"author":"fifarmacomunicaciones","twitter_card":"summary_large_image","twitter_misc":{"Written by":"fifarmacomunicaciones","Est. reading time":"4 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/fifarma.org\/que-es-el-ich-y-por-que-es-clave-para-fortalecer-la-regulacion-de-medicamentos-en-america-latina-copy\/#article","isPartOf":{"@id":"https:\/\/fifarma.org\/que-es-el-ich-y-por-que-es-clave-para-fortalecer-la-regulacion-de-medicamentos-en-america-latina-copy\/"},"author":{"name":"fifarmacomunicaciones","@id":"https:\/\/fifarma.org\/#\/schema\/person\/f1731f7484686defa417316a8fe42068"},"headline":"2025: un a\u00f1o en el que avanzamos juntos por la\u00a0salud en Am\u00e9rica Latina\u00a0","datePublished":"2025-12-26T14:09:03+00:00","dateModified":"2026-03-05T17:32:14+00:00","mainEntityOfPage":{"@id":"https:\/\/fifarma.org\/que-es-el-ich-y-por-que-es-clave-para-fortalecer-la-regulacion-de-medicamentos-en-america-latina-copy\/"},"wordCount":787,"publisher":{"@id":"https:\/\/fifarma.org\/#organization"},"image":{"@id":"https:\/\/fifarma.org\/que-es-el-ich-y-por-que-es-clave-para-fortalecer-la-regulacion-de-medicamentos-en-america-latina-copy\/#primaryimage"},"thumbnailUrl":"https:\/\/fifarma.org\/wp-content\/uploads\/2025\/12\/Blog-Fin-de-ano_Banner-Blog-scaled.jpg","keywords":["america latina","fifarma","salud"],"articleSection":["Comunicado"],"inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/fifarma.org\/que-es-el-ich-y-por-que-es-clave-para-fortalecer-la-regulacion-de-medicamentos-en-america-latina-copy\/","url":"https:\/\/fifarma.org\/que-es-el-ich-y-por-que-es-clave-para-fortalecer-la-regulacion-de-medicamentos-en-america-latina-copy\/","name":"2025: un a\u00f1o en el que avanzamos juntos por la\u00a0salud en Am\u00e9rica Latina\u00a0 - FIFARMA","isPartOf":{"@id":"https:\/\/fifarma.org\/#website"},"primaryImageOfPage":{"@id":"https:\/\/fifarma.org\/que-es-el-ich-y-por-que-es-clave-para-fortalecer-la-regulacion-de-medicamentos-en-america-latina-copy\/#primaryimage"},"image":{"@id":"https:\/\/fifarma.org\/que-es-el-ich-y-por-que-es-clave-para-fortalecer-la-regulacion-de-medicamentos-en-america-latina-copy\/#primaryimage"},"thumbnailUrl":"https:\/\/fifarma.org\/wp-content\/uploads\/2025\/12\/Blog-Fin-de-ano_Banner-Blog-scaled.jpg","datePublished":"2025-12-26T14:09:03+00:00","dateModified":"2026-03-05T17:32:14+00:00","breadcrumb":{"@id":"https:\/\/fifarma.org\/que-es-el-ich-y-por-que-es-clave-para-fortalecer-la-regulacion-de-medicamentos-en-america-latina-copy\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/fifarma.org\/que-es-el-ich-y-por-que-es-clave-para-fortalecer-la-regulacion-de-medicamentos-en-america-latina-copy\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/fifarma.org\/que-es-el-ich-y-por-que-es-clave-para-fortalecer-la-regulacion-de-medicamentos-en-america-latina-copy\/#primaryimage","url":"https:\/\/fifarma.org\/wp-content\/uploads\/2025\/12\/Blog-Fin-de-ano_Banner-Blog-scaled.jpg","contentUrl":"https:\/\/fifarma.org\/wp-content\/uploads\/2025\/12\/Blog-Fin-de-ano_Banner-Blog-scaled.jpg","width":2560,"height":1138},{"@type":"BreadcrumbList","@id":"https:\/\/fifarma.org\/que-es-el-ich-y-por-que-es-clave-para-fortalecer-la-regulacion-de-medicamentos-en-america-latina-copy\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Portada","item":"https:\/\/fifarma.org\/"},{"@type":"ListItem","position":2,"name":"2025: un a\u00f1o en el que avanzamos juntos por la\u00a0salud en Am\u00e9rica Latina\u00a0"}]},{"@type":"WebSite","@id":"https:\/\/fifarma.org\/#website","url":"https:\/\/fifarma.org\/","name":"FIFARMA","description":"Federaci\u00f3n Latinoamericana de la Industria Farmac\u00e9utica","publisher":{"@id":"https:\/\/fifarma.org\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/fifarma.org\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/fifarma.org\/#organization","name":"Fifarma","alternateName":"Federaci\u00f3n Latinoamericana de la Industria Farmac\u00e9utica","url":"https:\/\/fifarma.org\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/fifarma.org\/#\/schema\/logo\/image\/","url":"https:\/\/fifarma.org\/wp-content\/uploads\/2022\/10\/logo-fifarma.png","contentUrl":"https:\/\/fifarma.org\/wp-content\/uploads\/2022\/10\/logo-fifarma.png","width":195,"height":39,"caption":"Fifarma"},"image":{"@id":"https:\/\/fifarma.org\/#\/schema\/logo\/image\/"}},{"@type":"Person","@id":"https:\/\/fifarma.org\/#\/schema\/person\/f1731f7484686defa417316a8fe42068","name":"fifarmacomunicaciones","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/8af54b74d81934872c5e9bf852bec4021ca6d3043cf2132e25087b2d09318d1c?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/8af54b74d81934872c5e9bf852bec4021ca6d3043cf2132e25087b2d09318d1c?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/8af54b74d81934872c5e9bf852bec4021ca6d3043cf2132e25087b2d09318d1c?s=96&d=mm&r=g","caption":"fifarmacomunicaciones"}}]}},"_links":{"self":[{"href":"https:\/\/fifarma.org\/en\/wp-json\/wp\/v2\/posts\/9586","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/fifarma.org\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/fifarma.org\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/fifarma.org\/en\/wp-json\/wp\/v2\/users\/24"}],"replies":[{"embeddable":true,"href":"https:\/\/fifarma.org\/en\/wp-json\/wp\/v2\/comments?post=9586"}],"version-history":[{"count":0,"href":"https:\/\/fifarma.org\/en\/wp-json\/wp\/v2\/posts\/9586\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/fifarma.org\/en\/wp-json\/wp\/v2\/media\/9591"}],"wp:attachment":[{"href":"https:\/\/fifarma.org\/en\/wp-json\/wp\/v2\/media?parent=9586"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/fifarma.org\/en\/wp-json\/wp\/v2\/categories?post=9586"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/fifarma.org\/en\/wp-json\/wp\/v2\/tags?post=9586"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}